Ngā hua rapu kaituhi :: APM

1

Ets Gene PEA3 Cooperates with β-Catenin-Lef-1 and c-Jun in Regulation of Osteopontin Transcription mā Mohamed El‐Tanani, Angela Platt‐Higgins, Philip S. Rudland, F C Campbell

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Expression of calcium-binding protein S100A2 in breast lesions mā Dun Liu, Philip S. Rudland, D. Ross Sibson, Angela Platt‐Higgins, Roger Barraclough

I whakaputaina 2000

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Human Homologue of Cement Gland Protein, a Novel Metastasis Inducer Associated with Breast Carcinomas mā Dong Liu, Philip S. Rudland, D. Ross Sibson, Angela Platt‐Higgins, Dong L. Barraclough

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Induction of Metastasis by S100P in a Rat Mammary Model and Its Association with Poor Survival of Breast Cancer Patients mā Guozheng Wang, Angela Platt‐Higgins, Joe Carroll, Suzete de Silva Rudland, John Winstanley, Roger Barraclough, Philip S. Rudland

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer mā Angela Platt‐Higgins, Christine Renshaw, Christopher R. West, John Winstanley, Suzete de Silva Rudland, Roger Barraclough, Philip S. Rudland

I whakaputaina 2000

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

The Metastasis-Associated Anterior Gradient 2 Protein Is Correlated with Poor Survival of Breast Cancer Patients mā Dong L. Barraclough, Angela Platt‐Higgins, Suzete de Silva Rudland, Roger Barraclough, John Winstanley, Christopher R. West, Philip S. Rudland

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

The long term prognostic significance of c-erbB-2 in primary breast cancer mā John Winstanley, T Cooke, Gordon Murray, Angela Platt‐Higgins, W.D. George, S. Holt, M Myskov, A. Spedding, B. R. Barraclough, PS Rudland

I whakaputaina 1991

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients mā Helen Innes, Dun Liu, Roger Barraclough, Michael Davies, P A O'Neill, Angela Platt‐Higgins, Suzete de Silva Rudland, D. Ross Sibson, Philip S. Rudland

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. mā Suzete de Silva Rudland, L Martín, Chandeene Roshanlall, John Winstanley, Sam Leinster, Angela Platt‐Higgins, Joe Carroll, Christopher R. West, Roger Barraclough, Philip S. Rudland

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ mā Waseem Al-Jameel, Gou Xiao-jun, Xi Jin, Jiacheng Zhang, Qiang Wei, Jianzhong Ai, Hong Li, Asmaa M. S. Al-Bayati, Angela Platt‐Higgins, Andrew R. Pettitt, Philip S. Rudland, Youqiang Ke

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways mā Hiu‐Fung Yuen, Ka-Kui Chan, Claire Grills, James T. Murray, Angela Platt‐Higgins, Osama Sharaf Eldin, Kenneth J. O’Byrne, Pasi A. Jänne, Dean A. Fennell, Patrick G. Johnston, Philip S. Rudland, Mohamed El‐Tanani

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: